Cargando…

Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement

PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nan, Yang, Ruijie, Ren, Li, Fan, Yi, Li, Junli, Zhang, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689916/
https://www.ncbi.nlm.nih.gov/pubmed/28905514
http://dx.doi.org/10.1002/acm2.12173
_version_ 1783279485710237696
author Zhao, Nan
Yang, Ruijie
Ren, Li
Fan, Yi
Li, Junli
Zhang, Jianguo
author_facet Zhao, Nan
Yang, Ruijie
Ren, Li
Fan, Yi
Li, Junli
Zhang, Jianguo
author_sort Zhao, Nan
collection PubMed
description PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and anisotropy functions were calculated using the Monte Carlo code of MCNP5, and measured with thermoluminescent dosimeters (TLDs). The results were compared with those of PharmaSeed BT‐125‐1, PharmaSeed BT‐125‐2 (125)I, and model 6711 (125)I seeds. RESULTS: The dose rate constant of GMS BT‐125‐1 (125)I seed was 0.959 [Formula: see text] , with the difference of 0.94%, 0.83%, and 0.73% compared with the PharmaSeed BT‐125‐1 (125)I seed, PharmaSeed BT‐125‐2 (125)I seed, and Model 6711 (125)I seed, respectively. For radial dose function, the differences between the Monte Carlo and the experimental g(r) results were mostly within 10%. Monte Carlo results of g(r) for GMS BT‐125‐1 (125)I seed were found in agreement (within 3.3%) with corresponding results for the PharmaSeed BT‐125‐2 (125)I seed. The largest differences were 8.1% and 6.2% compared with PharmaSeed BT‐125‐1 (125)I seed and model 6711 (125)I seed, respectively. For anisotropy function, the difference between GMS BT‐125‐1 (125)I seed and PharmaSeed BT‐125‐2 (125)I seed was typically <10%. CONCLUSIONS: The measured dose rate constant, radial dose functions, and two‐dimensional anisotropy functions for the GMS BT‐125‐1 (125)I seed showed good agreement with the Monte Carlo results. The dose rate constant of the GMS BT‐125‐1 (125)I seed is similar to that of the PharmaSeed BT‐125‐1 (125)I seed, the PharmaSeed BT‐125‐2 (125)I seed, and the model 6711 (125)I seed. For radial dose functions and two‐dimensional anisotropy functions, the GMS BT‐125‐1 (125)I seed is similar to the PharmaSeed BT‐125‐2 (125)I seed but different from the PharmaSeed BT‐125‐1 (125)I seed and the model 6711 (125)I seed.
format Online
Article
Text
id pubmed-5689916
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56899162018-04-02 Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement Zhao, Nan Yang, Ruijie Ren, Li Fan, Yi Li, Junli Zhang, Jianguo J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and anisotropy functions were calculated using the Monte Carlo code of MCNP5, and measured with thermoluminescent dosimeters (TLDs). The results were compared with those of PharmaSeed BT‐125‐1, PharmaSeed BT‐125‐2 (125)I, and model 6711 (125)I seeds. RESULTS: The dose rate constant of GMS BT‐125‐1 (125)I seed was 0.959 [Formula: see text] , with the difference of 0.94%, 0.83%, and 0.73% compared with the PharmaSeed BT‐125‐1 (125)I seed, PharmaSeed BT‐125‐2 (125)I seed, and Model 6711 (125)I seed, respectively. For radial dose function, the differences between the Monte Carlo and the experimental g(r) results were mostly within 10%. Monte Carlo results of g(r) for GMS BT‐125‐1 (125)I seed were found in agreement (within 3.3%) with corresponding results for the PharmaSeed BT‐125‐2 (125)I seed. The largest differences were 8.1% and 6.2% compared with PharmaSeed BT‐125‐1 (125)I seed and model 6711 (125)I seed, respectively. For anisotropy function, the difference between GMS BT‐125‐1 (125)I seed and PharmaSeed BT‐125‐2 (125)I seed was typically <10%. CONCLUSIONS: The measured dose rate constant, radial dose functions, and two‐dimensional anisotropy functions for the GMS BT‐125‐1 (125)I seed showed good agreement with the Monte Carlo results. The dose rate constant of the GMS BT‐125‐1 (125)I seed is similar to that of the PharmaSeed BT‐125‐1 (125)I seed, the PharmaSeed BT‐125‐2 (125)I seed, and the model 6711 (125)I seed. For radial dose functions and two‐dimensional anisotropy functions, the GMS BT‐125‐1 (125)I seed is similar to the PharmaSeed BT‐125‐2 (125)I seed but different from the PharmaSeed BT‐125‐1 (125)I seed and the model 6711 (125)I seed. John Wiley and Sons Inc. 2017-09-14 /pmc/articles/PMC5689916/ /pubmed/28905514 http://dx.doi.org/10.1002/acm2.12173 Text en © 2017 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Zhao, Nan
Yang, Ruijie
Ren, Li
Fan, Yi
Li, Junli
Zhang, Jianguo
Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title_full Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title_fullStr Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title_full_unstemmed Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title_short Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
title_sort dosimetric characterization of gms bt‐125‐1 (125)i radioactive seed with monte carlo simulations and experimental measurement
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689916/
https://www.ncbi.nlm.nih.gov/pubmed/28905514
http://dx.doi.org/10.1002/acm2.12173
work_keys_str_mv AT zhaonan dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement
AT yangruijie dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement
AT renli dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement
AT fanyi dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement
AT lijunli dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement
AT zhangjianguo dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement